Shane Hewitt speaks with Tony Chapman about the growing use of Ozempic beyond diabetes treatment. Chapman questions whether pharmaceutical marketing is pushing prescription shortcuts over long-term lifestyle changes, and warns about potential health consequences.

Connect with 580 CFRA Online:
Subscribe to 580 CFRA: https://bit.ly/4o8AKWp
Visit the website: https://www.cfra.com/
Likes us on Facebook: https://bit.ly/47YzDm4

source